A medicinal product given on a compassionate basis is first and foremost a treatment.

Compassionate use only applies to medicines that are not yet authorised for any condition.

And society has a response to these patients that is “compassionate use”.

AB Science announces that FDA approves first compassionate use of masitinib in amyotrophic lateral sclerosis

Often, case-by-case approval must be obtained for compassionate use of a medicine or therapy.

In some cases of compassionate use, a Treatment Investigational New Drug (t-IND) may be obtained under specific conditions :

Often, case-by-case approval must be obtained from the FA for "compassionate use" of a drug or therapy.

Often, case-by-case approval must be obtained from the FA for "compassionate use" of a drug or therapy.

Often, case-by-case approval must be obtained for compassionate use of a medicine or therapy.

This section explains how your physician can request authorisation to prescribe to you a medicine on a compassionate basis

In Burzynski's case, these "compassionate use" exceptions were common, FDA records show.

This drug has already been administered to over 2,300 patients, either in clinical trials, or for compassionate use.

Others are available through clinical trials primarily also through compassionate use programs in some countries.

In addition, this Service is the only one in Spain that can provide treatment with human recombinant leptin for compassionate use.

The patient organisation in your country may know which compassionate access programs are available.